Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: AstraZeneca(AZN) the Revenue is 15.38 B (+6.41%), Miss estimate;the EBIT is 5.158 B (+12.52%), Beat estimate;the EPS is 0.805 (+2.55%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
15.38B6.41%
15.42B6.64%
-0.03B0.23%
EBITExceed expectations
5.16B12.52%
5.10B11.27%
+0.06B1.25%
EPSMiss expectations
0.8052.55%
1.098939.99%
-0.293937.44%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateOct 30, 2026
Estimate Revenue16.06 B
Estimate EBIT5.456 B
Estimate EPS1.1661
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf